Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Renovacor Inc (RCOR)

Renovacor Inc (RCOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,261
  • Shares Outstanding, K 17,269
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,100 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.29
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.06
  • Most Recent Earnings $-0.52 on 08/08/22
  • Next Earnings Date 12/05/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.77
  • Number of Estimates 1
  • High Estimate -0.77
  • Low Estimate -0.77
  • Prior Year -0.54
  • Growth Rate Est. (year over year) -42.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.10 +52.37%
on 11/22/22
3.37 -4.90%
on 11/15/22
+0.14 (+4.58%)
since 10/28/22
3-Month
1.65 +93.94%
on 09/07/22
3.37 -4.90%
on 11/15/22
+1.56 (+95.12%)
since 08/30/22
52-Week
1.34 +138.81%
on 06/15/22
9.74 -67.15%
on 12/10/21
-5.55 (-63.43%)
since 11/26/21

Most Recent Stories

More News
Rocket Pharmaceuticals Completes Acquisition of Renovacor

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet...

RCOR : 3.20 (+4.92%)
RCKT : 12.78 (-1.99%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCOR, SMBC, TALO, BTRS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RCOR : 3.20 (+4.92%)
SMBC : 65.00 (+0.68%)
TALO : 11.66 (+1.83%)
BTRS : 9.49 (-0.11%)
SHAREHOLDER ALERT: Weiss Law Reminds RCOR, BTRS, AERC, and AKUS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

RCOR : 3.20 (+4.92%)
BTRS : 9.49 (-0.11%)
AERC : 3.40 (+0.59%)
AKUS : 13.29 (+1.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, SMBC, TALO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RCKT : 12.78 (-1.99%)
RCOR : 3.20 (+4.92%)
SMBC : 65.00 (+0.68%)
TALO : 11.66 (+1.83%)
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

RCOR : 3.20 (+4.92%)
RCKT : 12.78 (-1.99%)
SHAREHOLDER ALERT: Weiss Law Reminds LFG, ECOM, LOTZ, and RCOR Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LFG : 26.00 (unch)
BP : 29.33 (+0.86%)
ECOM : 23.09 (+0.04%)
LOTZ : 0.1480 (-1.99%)
RCOR : 3.20 (+4.92%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCOR, SMBC, TALO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RCOR : 3.20 (+4.92%)
SMBC : 65.00 (+0.68%)
TALO : 11.66 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

EQ : 0.6919 (-3.65%)
RCKT : 12.78 (-1.99%)
RMED : 0.5940 (+10.00%)
RCOR : 3.20 (+4.92%)
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SBTX : 5.87 (+1.03%)
RMED : 0.5940 (+10.00%)
RCOR : 3.20 (+4.92%)
BTRS : 9.49 (-0.11%)
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

RCOR : 3.20 (+4.92%)
RCKT : 12.78 (-1.99%)

Business Summary

Renovacor Inc. is an early'stage biotechnology company developing adeno-associated virus based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants. Renovacor Inc., formerly known as Chardan Healthcare Acquisition 2 Corp., is based in NEW...

See More

Key Turning Points

3rd Resistance Point 3.47
2nd Resistance Point 3.33
1st Resistance Point 3.27
Last Price 3.20
1st Support Level 3.07
2nd Support Level 2.93
3rd Support Level 2.87

See More

52-Week High 9.74
Fibonacci 61.8% 6.53
Fibonacci 50% 5.54
Fibonacci 38.2% 4.55
Last Price 3.20
52-Week Low 1.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar